Sobi, Inc. Leadership

Rami Levin - President, Sobi North America

Rami Levin - President, North America

Employed since January 2014. MBA - Rekanati Business School, Tel-Aviv University, Israel. BSc in Biology - Tel-Aviv University, Israel. Over 18 years of experience in the pharmaceutical industry in a variety of Marketing, Sales and General Management leadership roles in different countries.

Previous positions: Various senior positions within Merck Serono since 1998, most recently as Vice President of Marketing (US) 2012-2014. Managing Director Scandinavia (Sweden) 2008-2012. Global Marketing Head (Switzerland) 2001-2008. Business Unit Manager (Israel) 1998-2001. Product Manager, Schering AG (Israel) 1996-1998.

Linea Aspesi - Vice President, Human Resources, Sobi North America

Linea Aspesi - Vice President, Human Resources, North America

Employed since January 2018. More than 20 years of proven success aligning talent priorities with business strategy. Experience spanning talent acquisition, management and retention; performance management; total rewards; organizational design; and employee relations.

Previous positions: Multiple positions in human resources at Sanofi, 2008 – 2017, most recently head of human resources for the Industrial Affairs organization in the U.S. Also served as a member of the Sanofi North America HR Leadership Team, the global HR Industrial Affairs Council and the U.S. Industrial Affairs Country Council. Previously held HR positions at multiple healthcare organizations including UMass Memorial Medical Center (2005-2008) and Partners Healthcare System Inc. (2002-2005).

Christine Belin - Vice President, Finance, Sobi North America

Christine Belin - Vice President, Finance, North America

Employed since September 2014. MBA- Johnson Graduate School of Management at Cornell University, BS in Chemical Engineering from Cornell University. Over 15 years of experience in the pharmaceutical industry in a variety of finance leadership roles.

Previous positions: Director of Finance and Revenue Accounting at Ariad Pharmaceuticals 2013-2014, Director of Commercial Financial Planning and Analysis at Human Genome Sciences 2010-2013, and various positions at Amgen from 2002 through 2010 including Director of Finance for Colorado Operations 2007-2010 and Senior Finance Manager of Europe R&D at Amgen, Ltd in Cambridge, UK 2005-2007. Before Amgen, she worked as a reservoir engineer at Shell Exploration and Production Co.

Matthew Boyd - Vice President, Head of Regulatory Affairs, Sobi North America

Matthew Boyd - Vice President, Regulatory Affairs, North America

Employed since September 2014. MBA - Indiana University, Kelley School of Business, B.Sc. in Pharmacy - University of the Sciences, Philadelphia College of Pharmacy.

Previous positions: Various positions within Merck Serono since 2005, most recently as Director of Digital and Social Media, Global Marketing Excellence (2012-2014). Director US Regulatory Affairs (2009-2012). Director US Regulatory Affairs, Sanofi (US) 2005-2009. Associate Director Global Promotion Compliance and Labeling, Bristol-Myers Squibb (US) 2001-2005.

Heather Golding - Vice President, Head of Legal and Compliance, Sobi North America

Heather Golding - Vice President, Legal and Compliance, North America

Employed since November 2015. J.D. – University of Connecticut School of Law. B.A. –International Studies, Colby College. Over 10 years of experience providing legal and compliance guidance to the pharmaceutical industry. 

Previous positions: Director, Legal and Compliance at Takeda Oncology (formerly Millennium Pharmaceuticals) (2013-2015); Assoc. Director, Corporate Compliance at Takeda Oncology (2011-2013). Associate, Government Enforcement and Compliance Practice Group at Choate, Hall & Stewart LLP (2005-2011). Special Assistant District Attorney, Suffolk County, MA (2010). 

Jeff Henderson - Vice President, Head of Market Access and Government Affairs, U.S.

Employed since July 2018. Nearly 30 years of experience in the pharmaceutical and biotech industry with multiple roles in patient access, payer strategies, managed markets and government relations.
Previous positions: Vice President of Managed Markets at Intarcia Therapeutics, Inc., 2015-2018. Vice President of Managed Markets at Vertex Pharmaceuticals, Inc., 2010-2014. Multiple roles at Pfizer, Inc. from 1991-2010, such as Southeast Regional Business Unit Lead of Corporate and Government Customers; Vice President of Customer Business Unit Liaison Group; Vice President, Sales, of Managed Markets West; and Senior Director of National Accounts.

Holly May - Vice President, Sales and Marketing, Sobi United States

Holly May - Vice President, Sales and Marketing, United States

Employed since January 2018. Proven commercial leader with 20 years’ experience in sales and marketing. Specific expertise in rare diseases, commercial strategies, commercial analytics, launch readiness and life-cycle management.

Previous positions: Multiple positions at Sanofi, 2000-2017, including vice president and head of U.S. Fabry and xLSD marketing at Sanofi Genzyme Rare Disease, vice president and head of U.S. Fabry at Genzyme Rare Disease, director of marketing operations and strategic planning of Sanofi’s Global Oncology Division, and regional sales director for Sanofi’s cardiovascular business unit. Multiple sales and marketing positions at DuPont Pharmaceuticals Co., DuPont Merck Pharmaceutical Co. and Endo LLC.

Bob McLay - General Manager, Sobi Canada

Bob McLay - General Manager, Canada

Employed since February 2016. MBA – Auburn University, Auburn Alabama. BSc – University of Guelph, Guelph, Ontario. Over 23 years of experience in the pharmaceutical industry with multiple leadership roles in marketing, sales, patient access, supply chain, trade relations and business development.

Previous Positions: Multiple senior level positions with both large and small pharmaceutical companies. Most recently, VP Sales and Marketing & Canadian Commercial Lead at Merus Labs International (2014-2015), Director of Sales at Takeda Canada (2012-2013), Marketing Director at Graceway Pharmaceuticals (2007-2012), Associate Sales Director and other various sales and marketing roles at Pfizer Canada (1994-2007).

Trista Morrison - Vice President, Head of Communications, Sobi North America

Trista Morrison - Vice President, Communications and Patient Advocacy, North America

Employed since July 2017. Over 15 years’ experience in biopharmaceutical communications, including corporate narrative, media relations, social media, crisis management, internal communications, product public relations and corporate social responsibility. Named a 2017 Top Woman in PR by PR News.

Previous positions: Director of corporate communications at Ironwood Pharmaceuticals, 2012-2017. Staff Writer for BioWorld Today and Editor for BioWorld Insight, 2006-2012. Various positions with biopharmaceutical-focused public relations agency Porter Novelli Life Sciences (formerly Atkins + Associates), 2001-2006.

Carol Satler, M.D., Ph.D. - Vice President, Head of Medical Affairs, Sobi North America

Carol Satler, M.D., Ph.D. - Vice President, Medical Affairs, North America

Employed since September 2018. More than 25 years of experience in the healthcare industry with multiple roles spanning medical affairs, clinical research and clinical practice. M.D. in pediatrics and Ph.D. from Case Western Reserve University.

Previous positions: Vice President & Therapeutic Area Head, Cardiovascular Clinical Research at Gilead Sciences, Inc., 2016-2018. Vice President of U.S. Medical Affairs, General Medicine at Bayer Healthcare Pharmaceuticals, Inc., 2013-2015. Vice President and Head, North America Medical Affairs at UCB, Inc., 2012-2013. Various medical and clinical roles at Millennium Pharmaceuticals, Inc.; Forest Research Institute, Inc.; 2008-2012. President and Chief Executive Officer at Indigo Pharmaceuticals, Inc., 2007-2008. Multiple roles at Sanofi and Pfizer, Inc. Trained and served on faculty at Harvard Medical School and Boston Children’s Hospital in Medicine, Pediatrics and Pediatric Cardiology for over a decade.